Oxygen Therapy in Chronic Obstructive Pulmonary Disease
- 1 May 2008
- journal article
- review article
- Published by American Thoracic Society in Proceedings of the American Thoracic Society
- Vol. 5 (4), 513-518
- https://doi.org/10.1513/pats.200708-124et
Abstract
Since the introduction of oxygen as a therapeutic agent 70 years ago, much has been learned regarding the detrimental effects of hypoxemia and the beneficial impact of oxygen therapy. It is projected that there are close to 800,000 patients receiving long-term oxygen therapy (LTOT) in the United States, at a cost of approximately $1.8 billion annually. The large numbers of patients receiving supplemental oxygen as treatment and the high costs incurred in providing oxygen therapy necessitate the practitioner to know the indications for LTOT as well its effects on survival, pulmonary hemodynamics, sleep, and exercise capacity. It is now recognized that the basis for LTOT prescription for all patients is founded on data that are over 25 years old and that only involve a very select cohort of patients. It is clear that further studies are required to assess the effects of oxygen on patients with chronic obstructive pulmonary disease with only mild hypoxemia, not only survival but also on neurocognitive function, quality of life, exercise physiology, and sleep quality. In addition, although proven to be safe when prescribed long term to individuals with lung disease, there are some concerns about worsening carbon dioxide retention and increased oxidant injury. The goals of this article are to briefly describe the indications for chronic oxygen administration, the physiologic effects of treatment, and potential toxicities, as well as its effect on morbidity and mortality.Keywords
This publication has 55 references indexed in Scilit:
- Sleep Disorders in the Elderly With and Without Chronic Airflow Obstruction: the SARA StudySleep, 2003
- HYPOXIA AND REOXYGENATION INCREASE H 2 O 2 PRODUCTION IN RATSExperimental Lung Research, 2003
- Effect of oxygen on breath markers of oxidative stressEuropean Respiratory Journal, 2002
- Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patientsEuropean Respiratory Journal, 2001
- Oxygen toxicity: simultaneous measure of pentane and malondialdehyde in humans exposed to hyperoxiaBiomedicine & Pharmacotherapy, 2001
- Effects of Hyperoxia on Ventilatory Limitation During Exercise in Advanced Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Signal Transduction Pathways in Hyperoxia-Induced Lung Cell DeathMolecular Genetics and Metabolism, 2000
- Recommendations of the Fifth Oxygen Consensus Conference. Writing and Organizing Committees.2000
- A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patientsEuropean Respiratory Journal, 1999
- Pathophysiology of DyspneaNew England Journal of Medicine, 1995